The Zhitong Finance App learned that on Friday, Moderna (MRNA.US) rose 10% intraday and hit a new high since December 2022. As of press release, the increase had narrowed to 7% to $210.95. According to the news, on October 9, Moderna was officially included in the Nasdaq 100 Index to replace Warner Bros. Exploration. After inclusion, some broad-based institutions that previously did not allocate biomedicine will be passively held, and active institutions will also put the company on the watch list to increase the attention of individual stocks.

Additionally, on October 7, the company expanded multi-year cooperation with MSD and Tempus to provide tumor sample collection, sequencing, and therapy design and production support for the potential commercialization of the individualized novel antigen therapy intismeran autogene.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.